<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJVM</journal-id><journal-title-group><journal-title>Open Journal of Veterinary Medicine</journal-title></journal-title-group><issn pub-type="epub">2165-3356</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojvm.2016.611020</article-id><article-id pub-id-type="publisher-id">OJVM-72461</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Understanding &lt;i&gt;Ehrlichia canis&lt;/i&gt; Infections in Dogs of Costa Rica: Hematological Findings and Indicative Clinical Signs
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alexander</surname><given-names>V. Barrantes-González</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ana</surname><given-names>E. Jiménez-Rocha</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Juan</surname><given-names>José Romero-Zuñiga</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gaby</surname><given-names>Dolz</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Programa de Investigación en Medicina Poblacional, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica</addr-line></aff><aff id="aff2"><addr-line>Laboratorio de Parasitología, Escuela de Medicina Veterinaria, Universidad Nacional, Heredia, Costa Rica</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>avbarrantesgonzalez@gmail.com(AVB)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>11</month><year>2016</year></pub-date><volume>06</volume><issue>11</issue><fpage>163</fpage><lpage>175</lpage><history><date date-type="received"><day>September</day>	<month>22,</month>	<year>2016</year></date><date date-type="rev-recd"><day>Accepted:</day>	<month>November</month>	<year>27,</year>	</date><date date-type="accepted"><day>November</day>	<month>30,</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background:
   
  A cross-sectional study combining different serological and molecular techniques for the detection of Ehrlichia
   
  canis
   
  in dogs
   
  was carried out to determine hemopathological findings and suggestive clinical signs associated with acute, subclinical and chronic infections in the dog population of Costa Rica. Objectives:
   
  The present study describes and analyzes, in a more representative sampling frame, the clinical and hematological presentation of E. canis infection in dogs of Costa Rica in all its clinical stages. Methods:
   
  A descriptive analysis of the clinical signs was performed from a 441-dog sample. Serological and molecular techniques for the detection of Ehrlichia canis in
   
  dogs were applied. One and two-way ANOVA were carried out to determine the effect of the infection status on the hematological parameters. Results:
   
  A total of 0.7% (3/407) dogs were found with acute (seronegative but PCR positive), 29.7% (121/407) with subclinical (seropositive and PCR negative), and 2.5% (10/407) with chronic
   
  (seropositive and PCR positive)
   
  E. canis
   infections. Significant hemopathological
   
  findings were determined
   
  in dogs with acute (thrombocytosis), subclinical
   
  and chronic (anemia, thrombocytopenia, leukopenia) E. canis infections. Conclusions:
   
  Future studies must determine if dogs with subclinical E. canis infections eliminated the agent without any medication, or if they continue to be persistently infected, and will develop the
   
  chronic disease at some point in their lives.
 
</p></abstract><kwd-group><kwd>Ehrlichiosis</kwd><kwd> Epidemiology</kwd><kwd> Hematopathology</kwd><kwd> Infectious Disease</kwd><kwd> Clinical Pathology</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Ehrlichiosis is caused by bacteria classified within the group of the alpha-proteobacte- ria, order Rickettsiales, family Anaplasmataceae, genus Ehrlichia [<xref ref-type="bibr" rid="scirp.72461-ref1">1</xref>] . This genus consists of obligate intracellular Gram-negative bacteria that mainly infect leukocytes such as monocytes, macrophages, and granulocytes [<xref ref-type="bibr" rid="scirp.72461-ref2">2</xref>] .</p><p>Monocytotropic canine ehrlichiosis is caused by Ehrlichia canis, which is found in the form of morulae in the cytoplasm of lymphocytes, monocytes, and macrophages [<xref ref-type="bibr" rid="scirp.72461-ref3">3</xref>] . The incubation period ranges from 8 to 20 days [<xref ref-type="bibr" rid="scirp.72461-ref4">4</xref>] followed by the acute, subclinical, and chronic stages of the disease.</p><p>The most important clinical signs of infection are fever, depression, lethargy, anorexia, weight loss, cardiac arrhythmias, hemorrhagic diathesis, central nervous system signs, lymphadenomegaly, splenomegaly, polyarthritis, uveitis anterior, ocular signs and blindness from retinal edema or bleeding and detachment. The most significant laboratory findings are thrombocytopenia, anemia, leukopenia, hyperglobulinemia, proteinuria, lymphocytic pleocytosis, and bone marrow plasmacytosis [<xref ref-type="bibr" rid="scirp.72461-ref4">4</xref>] .</p><p>The acute phase lasts between two to four weeks [<xref ref-type="bibr" rid="scirp.72461-ref5">5</xref>] and is characterized by fever, weight loss, anorexia, depression, lymphadenomegaly, splenomegaly, vasculitis, and ocular and musculoskeletal signs [<xref ref-type="bibr" rid="scirp.72461-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref8">8</xref>] . Thrombocytopenia is the most common abnormality in naturally or experimentally infected dogs in this phase of the disease [<xref ref-type="bibr" rid="scirp.72461-ref8">8</xref>] .</p><p>The subclinical phase has a duration that varies from months to years [<xref ref-type="bibr" rid="scirp.72461-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref9">9</xref>] . Dogs in this stage are known to be carriers of E. canis and remain clinically healthy for months or years [<xref ref-type="bibr" rid="scirp.72461-ref10">10</xref>] until they spontaneously recover from infection or develop severe illness. During this phase, the animal may show high anti-E. canis antibody titers [<xref ref-type="bibr" rid="scirp.72461-ref11">11</xref>] , persistent thrombocytopenia, and leucopenia with no other clinical signs [<xref ref-type="bibr" rid="scirp.72461-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref11">11</xref>] . Generally, bacterial DNA is not found in blood samples in this phase; spleen and bone marrow are the most appropriate tissues to analyze [<xref ref-type="bibr" rid="scirp.72461-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.72461-ref12">12</xref>] . Severe pancytopenia, hemorrhagic diathesis, and organism debilitation may characterize the chronic phase [<xref ref-type="bibr" rid="scirp.72461-ref5">5</xref>] . Although the conditions that can lead the animal to this stage are not totally clear, it has been suggested that factors such as breed, immune system deficiency, stress conditions, co-infections, virulence of the strain, and the geographical region could have some influence on the outcome of infection [<xref ref-type="bibr" rid="scirp.72461-ref10">10</xref>] .</p><p>E. canis was reported for the first time in dogs of Costa Rica by Meneses [<xref ref-type="bibr" rid="scirp.72461-ref13">13</xref>] . Romero et al. [<xref ref-type="bibr" rid="scirp.72461-ref14">14</xref>] analyzed blood samples from dogs with clinical signs or suspected of suffering ehrlichiosis, and found highly significant differences in hematocrit and hemoglobin values between PCR positive and negative dogs. In this population, 26.6% (8/30) were determined to have acute (seronegative and PCR positive) E. canis infections, while 20.0% (6/30) had subclinical (seropositive and PCR negative) and 6.6% (2/30) had chronic (seropositive and PCR positive) E. canis infections [<xref ref-type="bibr" rid="scirp.72461-ref14">14</xref>] . Another study carried out in four regions of Costa Rica found 58.0% (29/50) of dogs with subclinical E. canis infections [<xref ref-type="bibr" rid="scirp.72461-ref15">15</xref>] . The present study describes and analyzes, in a more representative sampling frame, the clinical and hematological presentation of E. canis infection in dogs of Costa Rica.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Study Design, Sample Size and Analyzed Population</title><p>A cross-sectional, observational, descriptive study was conducted to determine the presence of, or exposure to, Ehrlichia spp. in blood samples from dogs, using molecular and serological assays, respectively. The total sample size was estimated to be 385 individuals (50% prevalence, 95% confidence) for a population of more than 40,000 dogs, calculated using Win Episcope 2.0. More details of the population studied, sampling methodology and period of study are described in Barrantes-Gonz&#225;lez et al. [<xref ref-type="bibr" rid="scirp.72461-ref16">16</xref>] .</p></sec><sec id="s2_2"><title>2.2. Interview, Clinical Examination, and Sampling</title><p>Each owner was interviewed to obtain information about the place of origin, tick infestation, treatment of ticks, and signs suggestive of ehrlichiosis (fever, weight loss, depression, epistaxis, petechiae, ecchymosis, hematuria, dyspnea, cough, lymphade- nomegaly, ataxia, diarrhea and scrotal edema), observed by the owners at some point in the lives of their pets. Also, other important information was obtained like if their veterinarian had suspected ehrlichiosis in the past, if the dog was treated because of this suspicion, and finally the medications used to treat those dogs was investigated. Veterinarians made sure to ask the owners in an appropriate fashion, adapting their vocabulary to the educational level of the respondent, to ensure that the questions were understood correctly. Clinical examination was performed to determine attitude (weak, depressed, docile, alert, nervous, aggressive), capillary refill time (&gt;2 s was considered as delayed), color of mucous membranes (very pale, pale, pink, icteric), rectal tempe- rature (≥39.5˚C was considered as feverish) and clinical signs suggestive of ehrlichiosis (weight loss, epistaxis, petechiae, ecchymosis, hematuria, dyspnea, cough, lympha- denomegaly, ataxia, lameness, diarrhea and scrotal edema). Dogs that were treated with doxycycline were recorded. From stray dogs living in recreational parks, consent from the administration was obtained. Only clinical exam and sampling was performed.</p></sec><sec id="s2_3"><title>2.3. Blood Analysis</title><p>The HETTICH&#174; microcentrifuge (5 minutes &#215; 18,600 g) and DAMON/IEC hematocrit reader were used to determine hematocrit values. Blood smears were stained with Giemsa as described by Cowell et al. [<xref ref-type="bibr" rid="scirp.72461-ref17">17</xref>] to determine complete blood count (CBC).</p></sec><sec id="s2_4"><title>2.4. Serological Analysis</title><p>Two commercial techniques were used to detect antibodies against E. canis, “Speed Ehrli” Virbac, an Immunochromatography Membrane Assay (IMA) (Bio Veto Test, Rome, Italy; sensitivity 87%, specificity 95%) and “E. canis and A. phagocytophilum Canine IgG Antibody Kit”, an Indirect Immunofluorescence Assay (IFA) (Fuller Lab- oratories, California, USA; sensitivity and specificity 100%). The methodologies recommended by the manufacturers were used. Sera were analyzed in IFA only in one dilution (1:80). Sera that exhibited fluorescence in 1:80 dilution were considered positive in IFA. Results of the two tests were compared. “Parallel testing” methodology was used to determine the seroprevalence.</p></sec><sec id="s2_5"><title>2.5. Molecular Analysis</title><p>Extraction of DNA from blood samples was performed with the “Wizard Genomic” assay (Promega&#174;, Wisconsin, USA). The conventional nested PCR was carried out as described by Romero et al. [<xref ref-type="bibr" rid="scirp.72461-ref14">14</xref>] : Primers ECC and ECB were used in the first round to amplify a segment of the 16S rRNA of Ehrlichia spp. The second PCR was carried out using primers HE3 and ECAN5 for E. canis, primers HE3 and HE1 for E. chaffeensis, and HE3 and EE5 for amplifying E. ewingii. PCR products (389 to 396 bp) were purified using the QIAquick kit (QIAGEN&#174;), proceeding according to the manufacturer’s instructions, and sent to Macrogen (Seoul, Korea) for sequencing. Further detailed molecular analysis methodology is described in Barrantes-Gonz&#225;lez et al. [<xref ref-type="bibr" rid="scirp.72461-ref16">16</xref>] .</p></sec><sec id="s2_6"><title>2.6. Statistical Analysis</title><p>Data obtained from the interview, clinical examination and results of diagnostic tests (serology and PCR) were entered a digital database. A descriptive analysis of the results through measures of central tendency (mean), measures of dispersion (standard deviation and 95% confidence interval) and frequency (%) by factors was performed. The presence or absence of E. canis antigen and presence or absence of antibodies against E. canis was determined, and frequency distributions of positive and negative results were determined. One-way ANOVA was performed to determine the difference of means between positive and negative (serology and molecular detection separately) groups for each hematological variable. Two-way ANOVA was carried out to assess the difference of means between positive and negative groups per infection status (non-infected, acute, subclinical and chronic) to E. canis. The statistical analysis was performed using STATA IC 13 (Stata Corp., USA).</p></sec></sec>
<sec id="s3">
<title>3. Results</title>
<p>Of the total of dogs (n = 441) that participated in the study, 399 had owners, and it was possible to conduct an owner interview, while 42 (9.5%) dogs were residents of the parks and had no known owner. A total of 55.9% of the owners had observed ticks on their pets, only 2.0% (9/441) of the dogs were diagnosed previously by a veterinarian with ehrlichiosis; 77.8% of them had been treated (28.6% with doxycycline and 71.4% did not remember the name of the medication) to: “ehrlichiosis; seven dogs had been treated (2 with doxycycline, and 5 did not remember the name of the medication), and...” in 3.6% of cases (16 dogs) the veterinarians suspected that the pets had ehrlichiosis. Clinical signs suggestive of ehrlichiosis observed by the owners at some point in the lives of their pets were: bleeding (17.0%), petechiae (9.5%), weight loss (4.5%), and hematuria (1.8%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Clinical examination encountered abnormalities in only a minority of the dogs, such as attitude (weak 0.2%, depressed 0.7%, docile 16.1%), capillary refill time &gt; 2 seconds (5.2%), mucous membranes (very pale 1.1%, pale 11.1%), and rectal temperatures ≥ 39.5˚C (19.5%). Clinical abnormalities included weight loss (4.5%), lymphadenomegaly (2.0%), petechiae (1.6%), cough (0.9%), scrotal edema (0.9%), ataxia (0.5%) and hematuria (0.2%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Hematocrit and complete blood count (CBC) results from the total dog sample are shown in <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Analysis of hematological values of dogs that were seropositive and seronegative to E. canis determined a highly significant difference (p &lt; 0.001) in mean hematocrit, hemoglobin and platelet count values, and a weak difference (p = 0.05 - 0.10) in mean corpuscular hemoglobin concentration (MCHC), white blood count (WBC), specifi- cally, lymphocytes and monocytes values. In all cases, mean values for all the above variables were lower in seropositive than in seronegative dogs.</p>
<p>Also, analysis of dogs that were PCR positive and PCR negative to E. canis determined a highly significant difference in the mean values of lymphocytes and basophils, and a weak difference in the hematocrit and mean values between PCR positive and PCR negative dogs. In all cases, mean values for all the above variables were lower in positive than in negative dogs (<xref ref-type="table" rid="table2">Table 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Clinical signs observed by the owner in the past and clinical signs observed by the veterinarian at the moment of sampling</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Observed by owner # (%) n = 399</th><th align="center" valign="middle" >Observed by veterinarian at sampling # (%) n = 441</th></tr></thead><tr><td align="center" valign="middle" >Fever</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >86 (19.5)</td></tr><tr><td align="center" valign="middle" >Attitude</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Docile</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >71 (16.1)</td></tr><tr><td align="center" valign="middle" >Depressed</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >3 (0.7)</td></tr><tr><td align="center" valign="middle" >Weak</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >1 (0.2)</td></tr><tr><td align="center" valign="middle" >Mucous membranes</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Pale</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >49 (11.1)</td></tr><tr><td align="center" valign="middle" >Very pale</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >5 (1.1)</td></tr><tr><td align="center" valign="middle" >Capillary refill time &gt;2 s</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >23 (5.2)</td></tr><tr><td align="center" valign="middle" >Weight loss</td><td align="center" valign="middle" >18 (4.5)</td><td align="center" valign="middle" >21 (4.5)</td></tr><tr><td align="center" valign="middle" >Lymphadenomegaly</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >9 (2.0)</td></tr><tr><td align="center" valign="middle" >Petechiae</td><td align="center" valign="middle" >39 (9.5)</td><td align="center" valign="middle" >7 (1.6)</td></tr><tr><td align="center" valign="middle" >Cough</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4 (0.9)</td></tr><tr><td align="center" valign="middle" >Ataxia</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2 (0.5)</td></tr><tr><td align="center" valign="middle" >Hematuria</td><td align="center" valign="middle" >7 (1.8)</td><td align="center" valign="middle" >1 (0.2)</td></tr><tr><td align="center" valign="middle" >Bleeding</td><td align="center" valign="middle" >68 (17.0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Ecchymosis</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Dyspnea</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Lameness</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Diarrhea</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr><tr><td align="center" valign="middle" >Scrotal edema</td><td align="center" valign="middle" >0 (0)</td><td align="center" valign="middle" >0 (0)</td></tr></tbody></table></table-wrap></sec></body>
<back><ref-list><title>References</title><ref id="scirp.72461-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Shimada, T., Ishida, Y., Shimizu, M., et al. (2002) Monitoring C-Reactive Protein in Beagle Dogs Experimentally Inoculated with Ehrlichia canis. Veterinary Research Communications, 26, 171-177. https://doi.org/10.1023/A:1015290903332</mixed-citation></ref><ref id="scirp.72461-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Munhoz, T.D., Faria, J.L., Vargas-Hérnandez, G., et al. (2012) Experimental Ehrlichia canis Infection Changes Acute-Phase Proteins. Revista Brasileira de Parasitologia Veterinária, 21, 206-212. https://doi.org/10.1590/S1984-29612012000300006</mixed-citation></ref><ref id="scirp.72461-ref3"><label>3</label><mixed-citation publication-type="book" xlink:type="simple">Waner, T. and Harrus, S. (2000) Anemia of Inflammatory disease. In: Feldman, B.F., Zinkl, J.G. and Jain, N.C., Eds., Schalm’s Veterinary Hematology, Williams &amp; Wilkins, Philadelphia, 212-215.</mixed-citation></ref><ref id="scirp.72461-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Gaunt, S.D., Beall, M.J., Stillman, B.A., et al. (2010) Experimental Infection and Co-Infection of Dogs with Anaplasma platys and Ehrlichia canis: Hematologic, Serologic and Molecular Findings. Parasites &amp; Vectors, 3, 33. https://doi.org/10.1186/1756-3305-3-33</mixed-citation></ref><ref id="scirp.72461-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Harrus, S., Waner, T., Keysary, A., Aroch, I., Voet, H. and Bark, H. (1998) Investigation of Splenic Function in Canine Monocytic Ehrlichiosis. Veterinary Immunology and Immunopathology, 62: 15-27. https://doi.org/10.1016/S0165-2427(97)00127-X</mixed-citation></ref><ref id="scirp.72461-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Shipov, A., Klement, E., Reuveni-Tager, L., Waner, T. and Harrus, S. (2008) Prognostic Indicators for Canine Monocytic Ehrlichiosis. Veterinary Parasitology, 153, 131-138.https://doi.org/10.1016/j.vetpar.2008.01.009</mixed-citation></ref><ref id="scirp.72461-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Castro, M.B., Machado, R.Z., Aquino, L.P.T., Alessi, A.C. and Costa, M.T. (2004) Experimental Acute Canine Monocytic Ehrlichiosis: Clinicopathological and Immunopathological Findings. Veterinary Parasitology, 119, 73-86. https://doi.org/10.1016/j.vetpar.2003.10.012</mixed-citation></ref><ref id="scirp.72461-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Faria, J.L., Dagnone, A.S., Munhoz, T.D., et al. (2010) Ehrlichia canis Morulae and DNA Detection in Whole Blood and Spleen Aspiration Samples. Revista Brasileira de Parasitologia Veterinária, 19, 98-102. https://doi.org/10.4322/rbpv.01902006</mixed-citation></ref><ref id="scirp.72461-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">McClure, J.C., Crothers, M.L., Schaefer, J.J., et al. (2010) Efficacy of a Doxycycline Treatment Regimen Initiated during Three Different Phases of Experimental Ehrlichiosis. Antimicrobial Agents and Chemotherapy, 12, 5012-5020. https://doi.org/10.1128/AAC.01622-09</mixed-citation></ref><ref id="scirp.72461-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nair, A.D.S., Cheng, C., Ganta, C.K., et al. (2016) Comparative Experimental Infection Study in Dogs with Ehrlichia canis, E. chaffeensis, Anaplasma platys and A. phagocytophilum. PloS ONE, 11, e0148239. https://doi.org/10.1371/journal.pone.0148239</mixed-citation></ref><ref id="scirp.72461-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Harrus, S. and Waner, T. (2011) Diagnosis of Canine Monocytotropic Ehrlichiosis (Ehrlichia canis): An Overview. The Veterinary Journal, 187, 292-296. https://doi.org/10.1016/j.tvjl.2010.02.001</mixed-citation></ref><ref id="scirp.72461-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cowell, R.L., Tyler, R.D., Meinkoth, J.H. and DeNicola, D.B. (2008) Hematology of the Dog and Cat. 3rd Edition, Elsevier, Missouri, 20-38.</mixed-citation></ref><ref id="scirp.72461-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Barrantes-González, A.V., Jiménez-Rocha, A.E., Romero-Zu&amp;#241iga, J.J. and Dolz, G. (2016) Serology, Molecular Detection and Risk Factors of Ehrlichia canis Infection in Dogs in Costa Rica. Ticks and Tick-borne Diseases, 7, 1245-1251. https://doi.org/10.1016/j.ttbdis.2016.07.006</mixed-citation></ref><ref id="scirp.72461-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Rojas, A., Rojas, D., Montenegro, V., Gutiérrez, R., Yasur-Landau, D. and Baneth, G. (2014) Vector-Borne Pathogens in Dogs from Costa Rica: First Molecular Description of Babesia vogeli and Hepatozoon canis Infections with a High Prevalence of Monocytic Ehrlichiosis and the Manifestations of Co-Infection. Veterinary Parasitology, 199, 121-128.https://doi.org/10.1016/j.vetpar.2013.10.027</mixed-citation></ref><ref id="scirp.72461-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Romero, L.E., Meneses, A.I., Salazar, L., et al. (2011) First Isolation and Molecular Characterization of Ehrlichia canis in Costa Rica, Central America. Research in Veterinary Science, 91, 95-97. https://doi.org/10.1016/j.rvsc.2010.07.021</mixed-citation></ref><ref id="scirp.72461-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Meneses, A. (1995) First Report of Canine Ehrlichiosis in Costa Rica. Veterinary Record, 137, 46-47. https://doi.org/10.1136/vr.137.2.46</mixed-citation></ref><ref id="scirp.72461-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Harrus, S., Kenny, M., Miara, L., Aisenberg, I., Waner, T. and Shaw, S. (2004) Comparison of Simultaneous Splenic Sample PCR with Blood PCR for Diagnosis and Treatment of Experimental Ehrlichia canis Infection. Antimicrobial Agents and Chemotherapy, 48, 4488-4490. https://doi.org/10.1128/AAC.48.11.4488-4490.2004</mixed-citation></ref><ref id="scirp.72461-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Waner, T., Harrus, S., Bark, H., Bogin, E., Avidar, Y. and Keysary, A. (1997) Characterization of the Subclinical Phase of Canine Ehrlichiosis in Experimentally Infected Beagle Dogs. Veterinary Parasitology, 69, 307-317. https://doi.org/10.1016/S0304-4017(96)01130-2</mixed-citation></ref><ref id="scirp.72461-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Harrus, S., Warner, T., Aizenberg, I., Foley, J.E., Poland, A.M. and Bark, H. (1998) Amplification of Ehrlichial DNA from Dogs 34 Months after Infection with Ehrlichia canis. Journal of Clinical Microbiology, 36, 73-76.</mixed-citation></ref><ref id="scirp.72461-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Codner, E.C. and Farris-Smith, L.L. (1986) Characterization of the Subclinical Phase of Ehrlichiosis in Dogs. Journal of the American Veterinary Medical Association, 189, 47-50.</mixed-citation></ref><ref id="scirp.72461-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Waner, T., Harrus, S., Weiss, D.J., Bark, H. and Keysary, A. (1995) Demonstration of Serum Antiplatelet Antibodies in Experimental Acute Canine Ehrlichiosis. Veterinary Immunology and Immunopathology, 48, 177-182. https://doi.org/10.1016/0165-2427(95)05420-B</mixed-citation></ref><ref id="scirp.72461-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Dagnone, A.S., Morais, H.S.A. and Vidotto, O. (2001) Erliquiose nos animais e no homem [Ehrlichiosis in Animals and Humans]. Semina: Ciências Agrárias, 22, 191-201.</mixed-citation></ref><ref id="scirp.72461-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Waner, T., Keysary, A., Bark, H., Sharabani, E. and Harrus, S. (1999) Canine Monocytic Ehrlichiosis—An Overview. Israel Journal of Veterinary Medicine, 54, 103-107.</mixed-citation></ref><ref id="scirp.72461-ref24"><label>24</label><mixed-citation publication-type="book" xlink:type="simple">Neer, M.T. and Harrus, S. (2006) Ehrlichiosis, Neorickettsiosis, Anaplasmosis and Wolbachia Infection. In: Greene, C.E., Ed., Infectious Diseases of the Dog and Cat, Elsevier, Philadelphia, 203-216.</mixed-citation></ref><ref id="scirp.72461-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Greene, C.E. (2012) Infectious Diseases of the Dog and the Cat. 4th Edition, Elsevier, Missouri, 227-270.</mixed-citation></ref><ref id="scirp.72461-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Mylonakis, M.E., Koutinas, A.F., Billinis, C., et al. (2003) Evaluation of Cytology in the Diagnosis of Acute Canine Monocytic Ehrlichiosis (Ehrlichia canis): A Comparison between Five Methods. Veterinary Microbiology, 91, 197-204. https://doi.org/10.1016/S0378-1135(02)00298-5</mixed-citation></ref><ref id="scirp.72461-ref27"><label>27</label><mixed-citation publication-type="book" xlink:type="simple">Walker, D. (1996) Rickettsiae. In: Baron, S., Ed., Medical Microbiology, 4th Edition, University of Texas, Texas, Chapter 38.</mixed-citation></ref><ref id="scirp.72461-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Dumler, J.S., Barbet, A.F., Bekker, C.P., et al. (2001) Reorganization of Genera in the Families Rickettsiaceae and Anaplasmataceae in the Order Rickettsiales: Unification of Some Species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, Descriptions of Six New Species Combinations and Designation of Ehrlichia equi and “HE Agent” as Subjective Synonyms of Ehrlichia phagocythophila. International Journal of Systematic and Evolutionary Microbiology, 51, 2145-2165. https://doi.org/10.1099/00207713-51-6-2145</mixed-citation></ref></ref-list></back></article>